Robert J Mentz1, Michael A Babyak2, Vera Bittner2, Jerome L Fleg2, Steven J Keteyian2, Ann M Swank2, Ileana L Piña2, William E Kraus2, David J Whellan2, Christopher M O'Connor2, James A Blumenthal2. 1. From the Duke University Medical Center, Durham, NC (R.J.M., M.A.B., W.E.K., C.M.O'C., J.A.B.); University of Alabama at Birmingham (V.B.); National Heart, Lung, and Blood Institute, Bethesda, MD (J.L.F.); Henry Ford Hospital, Detroit, MI (S.J.K.); University of Louisville, KY (A.M.S.); Montefiore-Einstein Medical Center, New York, NY (I.L.P.); and Thomas Jefferson University, Philadelphia, PA (D.J.W.). robert.mentz@duke.edu. 2. From the Duke University Medical Center, Durham, NC (R.J.M., M.A.B., W.E.K., C.M.O'C., J.A.B.); University of Alabama at Birmingham (V.B.); National Heart, Lung, and Blood Institute, Bethesda, MD (J.L.F.); Henry Ford Hospital, Detroit, MI (S.J.K.); University of Louisville, KY (A.M.S.); Montefiore-Einstein Medical Center, New York, NY (I.L.P.); and Thomas Jefferson University, Philadelphia, PA (D.J.W.).
Abstract
BACKGROUND: Although studies have shown that depression is associated with worse outcomes in patients with heart failure, most studies have been in white patients. The impact of depression on outcomes in blacks with heart failure has not been studied. METHODS AND RESULTS: We analyzed 747 blacks and 1420 whites enrolled in Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training, which randomized 2331 patients with ejection fraction ≤35% tousual care with or without exercise training. We examined the association between depressive symptoms assessed by the Beck Depression Inventory-II (BDI-II) at baseline and after 3 months with all-cause mortality/hospitalization. A race by baseline BDI-II interaction was observed (P=0.003) in which elevated baseline scores were associated with worse outcomes in blacks versus whites. In blacks, the association was nonlinear with a hazard ratio of 1.44 (95% confidence interval, 1.24-1.68) when comparing the 75th and 25th percentile of BDI-II (score of 15 and 5, respectively). No race interaction was observed for mortality (P=0.34). There was no differential association between BDI-II change and outcomes in blacks versus whites. In blacks, an increase in BDI-II score from baseline to 3 months was associated with increased mortality/hospitalization (hazard ratio, 1.33; 95% confidence interval, 1.12-1.57 per 10 point increase), whereas a decrease was not related to outcomes. CONCLUSIONS: In blacks with heart failure, baseline symptoms of depression and worsening of symptoms over time are associated with increased all-cause mortality/hospitalization. Routine assessment of depressive symptoms in blacks with heart failure may help guide management. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00047437.
RCT Entities:
BACKGROUND: Although studies have shown that depression is associated with worse outcomes in patients with heart failure, most studies have been in white patients. The impact of depression on outcomes in blacks with heart failure has not been studied. METHODS AND RESULTS: We analyzed 747 blacks and 1420 whites enrolled in Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training, which randomized 2331 patients with ejection fraction ≤35% to usual care with or without exercise training. We examined the association between depressive symptoms assessed by the Beck Depression Inventory-II (BDI-II) at baseline and after 3 months with all-cause mortality/hospitalization. A race by baseline BDI-II interaction was observed (P=0.003) in which elevated baseline scores were associated with worse outcomes in blacks versus whites. In blacks, the association was nonlinear with a hazard ratio of 1.44 (95% confidence interval, 1.24-1.68) when comparing the 75th and 25th percentile of BDI-II (score of 15 and 5, respectively). No race interaction was observed for mortality (P=0.34). There was no differential association between BDI-II change and outcomes in blacks versus whites. In blacks, an increase in BDI-II score from baseline to 3 months was associated with increased mortality/hospitalization (hazard ratio, 1.33; 95% confidence interval, 1.12-1.57 per 10 point increase), whereas a decrease was not related to outcomes. CONCLUSIONS: In blacks with heart failure, baseline symptoms of depression and worsening of symptoms over time are associated with increased all-cause mortality/hospitalization. Routine assessment of depressive symptoms in blacks with heart failure may help guide management. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00047437.
Authors: Christopher M O'Connor; Wei Jiang; Maragatha Kuchibhatla; Susan G Silva; Michael S Cuffe; Dwayne D Callwood; Bosh Zakhary; Wendy Gattis Stough; Rebekka M Arias; Sarah K Rivelli; Ranga Krishnan Journal: J Am Coll Cardiol Date: 2010-08-24 Impact factor: 24.094
Authors: Andrew Sherwood; James A Blumenthal; Alan L Hinderliter; Gary G Koch; Kirkwood F Adams; Carla Sueta Dupree; Daniel R Bensimhon; Kristy S Johnson; Ranak Trivedi; Margaret Bowers; Robert H Christenson; Christopher M O'Connor Journal: J Am Coll Cardiol Date: 2011-01-25 Impact factor: 24.094
Authors: Wei Jiang; Ranga Krishnan; Maragatha Kuchibhatla; Michael S Cuffe; Carolyn Martsberger; Rebekka M Arias; Christopher M O'Connor Journal: Am J Cardiol Date: 2011-02-15 Impact factor: 2.778
Authors: Kirsten Bibbins-Domingo; Mark J Pletcher; Feng Lin; Eric Vittinghoff; Julius M Gardin; Alexander Arynchyn; Cora E Lewis; O Dale Williams; Stephen B Hulley Journal: N Engl J Med Date: 2009-03-19 Impact factor: 91.245
Authors: Christopher M O'Connor; David J Whellan; Kerry L Lee; Steven J Keteyian; Lawton S Cooper; Stephen J Ellis; Eric S Leifer; William E Kraus; Dalane W Kitzman; James A Blumenthal; David S Rendall; Nancy Houston Miller; Jerome L Fleg; Kevin A Schulman; Robert S McKelvie; Faiez Zannad; Ileana L Piña Journal: JAMA Date: 2009-04-08 Impact factor: 56.272
Authors: G Michael Felker; David Whellan; William E Kraus; Robert Clare; Faiez Zannad; Mark Donahue; Kirkwood Adams; Robert McKelvie; Ileana L Piña; Christopher M O'Connor Journal: Am Heart J Date: 2009-10 Impact factor: 4.749
Authors: Nicole Holzapfel; Bernd Löwe; Beate Wild; Dieter Schellberg; Christian Zugck; Andrew Remppis; Hugo A Katus; Markus Haass; Bernhard Rauch; Jana Jünger; Wolfgang Herzog; Thomas Müller-Tasch Journal: Heart Lung Date: 2009-01-21 Impact factor: 2.210
Authors: James A Blumenthal; Michael A Babyak; Christopher O'Connor; Steven Keteyian; Joel Landzberg; Jonathan Howlett; William Kraus; Stephen Gottlieb; Gordon Blackburn; Ann Swank; David J Whellan Journal: JAMA Date: 2012-08-01 Impact factor: 56.272
Authors: Jane Rimer; Kerry Dwan; Debbie A Lawlor; Carolyn A Greig; Marion McMurdo; Wendy Morley; Gillian E Mead Journal: Cochrane Database Syst Rev Date: 2012-07-11
Authors: Debra K Moser; Cynthia Arslanian-Engoren; Martha J Biddle; Misook Lee Chung; Rebecca L Dekker; Muna H Hammash; Gia Mudd-Martin; Abdullah S Alhurani; Terry A Lennie Journal: Curr Cardiol Rep Date: 2016-12 Impact factor: 2.931
Authors: Lauren B Cooper; Robert J Mentz; Jie-Lena Sun; Phillip J Schulte; Jerome L Fleg; Lawton S Cooper; Ileana L Piña; Eric S Leifer; William E Kraus; David J Whellan; Steven J Keteyian; Christopher M O'Connor Journal: Circ Heart Fail Date: 2015-11 Impact factor: 8.790
Authors: Katja Vu; Brian L Claggett; Jenine E John; Hicham Skali; Scott D Solomon; Thomas H Mosley; Janice E Williams; Anna Kucharska-Newton; Tor Biering-Sørensen; Amil M Shah Journal: J Am Heart Assoc Date: 2021-11-19 Impact factor: 6.106